{"id":"https://openalex.org/W7225002776","doi":"https://doi.org/10.1080/1750743x.2026.2755170","title":"Real-world outcomes of interleukin-17 inhibitors in familial Mediterranean fever-associated inflammatory conditions: a retrospective study","display_name":"Real-world outcomes of interleukin-17 inhibitors in familial Mediterranean fever-associated inflammatory conditions: a retrospective study","publication_year":2026,"publication_date":"2026-10-31","ids":{"openalex":"https://openalex.org/W7225002776","doi":"https://doi.org/10.1080/1750743x.2026.2755170","pmid":"https://pubmed.ncbi.nlm.nih.gov/42965319"},"language":"en","primary_location":{"id":"doi:10.1080/1750743x.2026.2755170","doi":"https://doi.org/10.1080/1750743x.2026.2755170","is_oa":false,"landing_page_url":"https://doi.org/10.1080/1750743x.2026.2755170","pdf_url":null,"source":{"id":"https://openalex.org/S71887004","display_name":"Immunotherapy","issn_l":"1750-743X","issn":["1750-743X","1750-7448"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immunotherapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024442488","display_name":"Burak Karakaya","orcid":"https://orcid.org/0000-0002-6184-7876","observed_orcids":["https://orcid.org/0000-0002-6184-7876"]},"institutions":[{"id":"https://openalex.org/I95634034","display_name":"Gazi University","ror":"https://ror.org/054xkpr46","country_code":"TR","type":"education","lineage":["https://openalex.org/I95634034"]}],"countries":["TR"],"is_corresponding":true,"raw_author_name":"Burak Karakaya","raw_affiliation_strings":["Gazi University"],"raw_orcid":"https://orcid.org/0000-0002-6184-7876","affiliations":[{"raw_affiliation_string":"Gazi University","institution_ids":["https://openalex.org/I95634034"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055122215","display_name":"\u0130brahim Yahya \u00c7ak\u0131r","orcid":"https://orcid.org/0000-0003-0790-9519","observed_orcids":["https://orcid.org/0000-0003-0790-9519"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u0130brahim Yahya \u00c7ak\u0131r","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0790-9519","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5116688795","display_name":"\u0130. Karaduman","orcid":"https://orcid.org/0000-0003-4639-7464","observed_orcids":["https://orcid.org/0000-0003-4639-7464"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u0130brahim Karaduman","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4639-7464","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078624351","display_name":"Esma Esero\u011flu","orcid":"https://orcid.org/0000-0002-7020-3511","observed_orcids":["https://orcid.org/0000-0002-7020-3511"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Esma Esero\u011flu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7020-3511","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5116864218","display_name":"B\u00fcsra K\u00f6ksoy","orcid":"https://orcid.org/0009-0009-1139-5232","observed_orcids":["https://orcid.org/0009-0009-1139-5232"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B\u00fc\u015fra K\u00f6ksoy","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0009-1139-5232","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017671399","display_name":"Ertu\u011frul \u00c7a\u011fr\u0131 B\u00f6lek","orcid":"https://orcid.org/0000-0003-3886-2813","observed_orcids":["https://orcid.org/0000-0003-3886-2813"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ertu\u011frul \u00c7a\u011fr\u0131 B\u00f6lek","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3886-2813","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059943791","display_name":"Abd\u00fclsamet Erden","orcid":"https://orcid.org/0000-0002-8084-2018","observed_orcids":["https://orcid.org/0000-0002-8084-2018"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abdulsamet Erden","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8084-2018","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027090208","display_name":"Hamit K\u00fc\u00e7\u00fck","orcid":"https://orcid.org/0000-0003-1206-4725","observed_orcids":["https://orcid.org/0000-0003-1206-4725"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hamit K\u00fc\u00e7\u00fck","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1206-4725","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011026117","display_name":"Berna G\u00f6ker","orcid":"https://orcid.org/0000-0001-9242-0907","observed_orcids":["https://orcid.org/0000-0001-9242-0907"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Berna G\u00f6ker","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9242-0907","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101599952","display_name":"Mehmet Akif \u00d6zt\u00fcrk","orcid":"https://orcid.org/0000-0001-7203-3934","observed_orcids":["https://orcid.org/0000-0001-7203-3934"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mehmet Akif \u00d6zt\u00fcrk","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7203-3934","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5027801988","display_name":"Abdurrahman Tufan","orcid":"https://orcid.org/0000-0001-6244-9362","observed_orcids":["https://orcid.org/0000-0001-6244-9362"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abdurrahman Tufan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6244-9362","affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5024442488"],"corresponding_institution_ids":["https://openalex.org/I95634034"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.74888335,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"1","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11078","display_name":"Inflammasome and immune disorders","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11078","display_name":"Inflammasome and immune disorders","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11616","display_name":"Autoimmune and Inflammatory Disorders Research","score":0.0052999998442828655,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/il-17-inhibitors","display_name":"IL-17 inhibitors","score":0.9959999918937683},{"id":"https://openalex.org/keywords/familial-mediterranean-fever","display_name":"familial Mediterranean fever","score":0.9980000257492065},{"id":"https://openalex.org/keywords/immune-mediated-inflammatory-diseases","display_name":"immune-mediated inflammatory diseases","score":0.8600000143051147},{"id":"https://openalex.org/keywords/spondyloarthritis","display_name":"spondyloarthritis","score":0.9610000252723694},{"id":"https://openalex.org/keywords/attack-frequency","display_name":"attack frequency","score":0.878000020980835},{"id":"https://openalex.org/keywords/c-reactive-protein","display_name":"C-reactive protein","score":0.9909999966621399},{"id":"https://openalex.org/keywords/bath-ankylosing-spondylitis-disease-activity-index","display_name":"BASDAI","score":0.9269999861717224},{"id":"https://openalex.org/keywords/asdas-crp","display_name":"ASDAS-CRP","score":0.9779999852180481},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.9049999713897705},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7229999899864197},{"id":"https://openalex.org/keywords/real-world-outcomes","display_name":"real-world outcomes","score":0.7919999957084656}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9089000225067139},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.8712999820709229},{"id":"https://openalex.org/C2779537928","wikidata":"https://www.wikidata.org/wiki/Q1144618","display_name":"Familial Mediterranean fever","level":3,"score":0.829800009727478},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.6543999910354614},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6331999897956848},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5595999956130981},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.3772999942302704},{"id":"https://openalex.org/C2777226972","wikidata":"https://www.wikidata.org/wiki/Q415343","display_name":"Etanercept","level":3,"score":0.3644999861717224},{"id":"https://openalex.org/C2779725882","wikidata":"https://www.wikidata.org/wiki/Q3655009","display_name":"Canakinumab","level":4,"score":0.337799996137619},{"id":"https://openalex.org/C2779722408","wikidata":"https://www.wikidata.org/wiki/Q1536078","display_name":"TNF inhibitor","level":4,"score":0.3330000042915344},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3109000027179718},{"id":"https://openalex.org/C2777453003","wikidata":"https://www.wikidata.org/wiki/Q4834648","display_name":"BASDAI","level":4,"score":0.25589999556541443}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1080/1750743x.2026.2755170","doi":"https://doi.org/10.1080/1750743x.2026.2755170","is_oa":false,"landing_page_url":"https://doi.org/10.1080/1750743x.2026.2755170","pdf_url":null,"source":{"id":"https://openalex.org/S71887004","display_name":"Immunotherapy","issn_l":"1750-743X","issn":["1750-743X","1750-7448"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immunotherapy","raw_type":"journal-article"},{"id":"pmid:42965319","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42965319","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immunotherapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W1867780443","https://openalex.org/W1981822566","https://openalex.org/W2079494090","https://openalex.org/W2083180635","https://openalex.org/W2090550034","https://openalex.org/W2096900384","https://openalex.org/W2156605473","https://openalex.org/W2771626336","https://openalex.org/W2793407600","https://openalex.org/W2895111641","https://openalex.org/W2940679238","https://openalex.org/W2964353829","https://openalex.org/W2991381530","https://openalex.org/W2996552716","https://openalex.org/W3002825154","https://openalex.org/W3017731722","https://openalex.org/W3045091446","https://openalex.org/W3081214708","https://openalex.org/W3159307981","https://openalex.org/W4220888329","https://openalex.org/W4289517036","https://openalex.org/W4360619036","https://openalex.org/W4387477955","https://openalex.org/W4388400282","https://openalex.org/W4415526196"],"related_works":["https://openalex.org/W2763597778","https://openalex.org/W1991378232","https://openalex.org/W2904757716","https://openalex.org/W3110066116","https://openalex.org/W2399512006","https://openalex.org/W3031439517","https://openalex.org/W2908932965","https://openalex.org/W2336409975","https://openalex.org/W4284705103","https://openalex.org/W2794018905"],"abstract_inverted_index":{"AIMS:":[0],"To":[1],"evaluate":[2],"the":[3,124],"real-world":[4],"effects":[5],"of":[6,120,123],"interleukin-17":[7],"(IL-17)":[8],"inhibitors":[9,35],"on":[10],"familial":[11],"Mediterranean":[12],"fever":[13],"(FMF)":[14],"activity":[15,52,70,136],"and":[16,42,58,83,100,105,155],"associated":[17,125],"immune-mediated":[18],"inflammatory":[19],"diseases":[20],"(IMIDs).":[21],"PATIENTS":[22],"AND":[23],"METHODS:":[24],"We":[25],"retrospectively":[26],"evaluated":[27],"16":[28],"patients":[29,66,96],"with":[30,67,97],"FMF":[31,44,69,135],"who":[32],"received":[33],"IL-17":[34,109,128],"primarily":[36],"for":[37],"coexisting":[38],"IMIDs":[39],"between":[40],"2015":[41],"2026.":[43],"attack":[45,72],"frequency,":[46],"C-reactive":[47],"protein":[48],"(CRP)":[49],"levels,":[50],"spondyloarthritis":[51],"indices,":[53],"treatment":[54],"duration,":[55],"discontinuation":[56],"reasons,":[57],"adverse":[59],"events":[60],"were":[61],"assessed.":[62],"RESULTS:":[63],"Among":[64],"13":[65],"available":[68,101],"data,":[71,103],"frequency":[73],"remained":[74],"unchanged":[75],"in":[76,80,85,114,137,149,158],"9":[77],"(69%),":[78],"increased":[79],"3":[81],"(23%),":[82],"decreased":[84],"1":[86],"(8%).":[87],"CRP":[88],"levels":[89],"did":[90,130],"not":[91,131],"significantly":[92],"improve.":[93],"In":[94],"six":[95],"FMF-spondyloarthritis":[98],"overlap":[99],"3-month":[102],"BASDAI":[104],"ASDAS-CRP":[106],"showed":[107],"improvement.":[108],"inhibitor":[110],"therapy":[111],"was":[112,147],"discontinued":[113],"14":[115],"patients,":[116],"most":[117],"commonly":[118],"because":[119],"inadequate":[121],"control":[122],"IMID.":[126],"CONCLUSIONS:":[127],"inhibition":[129],"consistently":[132],"improve":[133],"core":[134],"this":[138],"highly":[139],"selected,":[140],"treatment-refractory":[141],"cohort,":[142],"although":[143],"some":[144],"domain-specific":[145],"benefit":[146],"observed":[148],"spondyloarthritis.":[150],"These":[151],"findings":[152],"are":[153],"hypothesis-generating":[154],"require":[156],"confirmation":[157],"prospective":[159],"controlled":[160],"studies.":[161]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2026-11-01T00:00:00"}